有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-phenyl-4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylsulfanylmethyl)-1,3-thiazol-2-amine | —— | C17H19N5S2 |
|
—— | N-(cyclohexen-1-yl)-N-cyclopropyl-2-[[5-(pyrrolidin-1-ium-1-ylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C18H27N4O2S+ |
|
—— | N-hydroxy-N-(5,6,7,8-tetrahydro-[1,2,4]triazolo[5,1-b][1,3]thiazepin-2-ylmethyl)acetamide | —— | C9H14N4O2S |
|
—— | 5-[(1-Cyclopropyltetrazol-5-yl)sulfanylmethyl]-3-thiophen-3-yl-1,2,4-oxadiazole | —— | C11H10N6OS2 |
|
—— | (3R)-3-hydroxy-3-(5,6,7,8-tetrahydroimidazo[2,1-b][1,3]thiazepin-2-yl)propanoic acid | —— | C10H14N2O3S |
|
—— | (2S)-2-(6,7-dihydro-5H-[1,2,4]triazolo[5,1-b][1,3]thiazin-2-yl)-3-methylbutanoic acid | —— | C10H15N3O2S |
|
—— | (2R)-2-(6,7-dihydro-5H-[1,2,4]triazolo[5,1-b][1,3]thiazin-2-yl)-3-methylbutanoic acid | —— | C10H15N3O2S |
|
—— | (2S)-2-(5,6,7,8-tetrahydro-[1,2,4]triazolo[5,1-b][1,3]thiazepin-2-yl)butanoic acid | —— | C10H15N3O2S |
|
—— | N-hydroxy-N-(5,6,7,8-tetrahydroimidazo[2,1-b][1,3]thiazepin-2-ylmethyl)acetamide | —— | C10H15N3O2S |
|
—— | (2R)-2-(5,6,7,8-tetrahydro-[1,2,4]triazolo[5,1-b][1,3]thiazepin-2-yl)butanoic acid | —— | C10H15N3O2S |
|
—— | (3R)-3-hydroxy-3-(2,3,4,5-tetrahydropyrrolo[2,1-b][1,3]thiazepin-8-yl)propanoic acid | —— | C11H15NO3S |
|
—— | (3S)-3-hydroxy-3-(5,6,7,8-tetrahydroimidazo[2,1-b][1,3]thiazepin-2-yl)propanoic acid | —— | C10H14N2O3S |
|
—— | (3R)-3-hydroxy-3-(5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]thiazepin-2-yl)propanoic acid | —— | C10H14N2O3S |
|
—— | (3S)-3-hydroxy-3-(2,3,4,5-tetrahydropyrrolo[2,1-b][1,3]thiazepin-8-yl)propanoic acid | —— | C11H15NO3S |
|
—— | 2-(1-cyclopropyltetrazol-5-yl)sulfanyl-1-[2,5-dimethyl-1-[(1S)-1-phenylethyl]pyrrol-3-yl]ethanone | —— | C20H23N5OS |
|
—— | (3S)-3-(5,6,7,8-tetrahydro-[1,2,4]triazolo[5,1-b][1,3]thiazepin-2-yl)butanoic acid | —— | C10H15N3O2S |
|
—— | 2-(1-cyclopropyltetrazol-5-yl)sulfanyl-N-[(1-morpholin-4-ylcyclohexyl)methyl]acetamide | —— | C17H28N6O2S |
|
—— | (3S)-3-hydroxy-3-(5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]thiazepin-2-yl)propanoic acid | —— | C10H14N2O3S |
|
—— | N-[(3R)-1,1-dioxothiolan-3-yl]-N-ethyl-2-[[4-(4-methylphenyl)-1,3-thiazol-2-yl]sulfanyl]acetamide | —— | C18H22N2O3S3 |
|
—— | N-(cyclohexen-1-yl)-N-ethyl-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C14H21N3OS |
|
—— | N-hydroxy-N-(2,3,4,5-tetrahydropyrrolo[2,1-b][1,3]thiazepin-8-ylmethyl)acetamide | —— | C11H16N2O2S |
|
—— | 4-[(1-Cyclopentyltetrazol-5-yl)sulfanylmethyl]-2-phenyl-1,3-thiazole | —— | C16H17N5S2 |
|
—— | (2R)-N-carbamoyl-2-(1-propylimidazol-2-yl)sulfanylpropanamide | —— | C10H16N4O2S |
|
—— | (9aR)-3-(2-cyclohexylethyl)-7,8,9,9a-tetrahydro-6H-[1,2,4]triazolo[4,3-b][4,1,2]benzothiadiazine | —— | C16H24N4S |
|
—— | 2-(Pyrrolidin-1-ium-1-ylmethyl)-5-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)methylsulfanyl]-1,3,4-oxadiazole | —— | C14H16N5O2S2+ |
|
—— | N-(3,4-dihydro-2H-pyrrolo[2,1-b][1,3]thiazin-7-ylmethyl)-N-hydroxyacetamide | —— | C10H14N2O2S |
|
—— | N-(6,7-dihydro-5H-[1,2,4]triazolo[5,1-b][1,3]thiazin-2-ylmethyl)-N-hydroxyacetamide | —— | C8H12N4O2S |
|
—— | N-(6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazin-2-ylmethyl)-N-hydroxyacetamide | —— | C9H13N3O2S |
|
—— | N-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]thiazin-2-ylmethyl)-N-hydroxyacetamide | —— | C9H13N3O2S |
|
—— | N-[(5-chlorothiophen-2-yl)methyl]-2-(4,6-diaminopyrimidin-2-yl)sulfanyl-N-methylacetamide | —— | C12H14ClN5OS2 |
|
—— | 1-[2,5-dimethyl-1-[[(2S)-oxolan-2-yl]methyl]pyrrol-3-yl]-2-[1-(thiophen-2-ylmethyl)tetrazol-5-yl]sulfanylethanone | —— | C19H23N5O2S2 |
|
—— | N-hydroxy-N-[(6-methyl-2-methylsulfanylpyrimidin-4-yl)methyl]acetamide | —— | C9H13N3O2S |
|
—— | N-hydroxy-N-[(2-methylsulfanylpyrimidin-4-yl)methyl]acetamide | —— | C8H11N3O2S |
|
—— | N-(2,3-dihydropyrrolo[2,1-b][1,3]thiazol-6-ylmethyl)-N-hydroxyacetamide | —— | C9H12N2O2S |
|
—— | N-hydroxy-N-[(2-methylsulfanylpyrimidin-5-yl)methyl]acetamide | —— | C8H11N3O2S |
|
—— | N-(2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-ylmethyl)-N-hydroxyacetamide | —— | C8H11N3O2S |
|
—— | N-(2,3-dihydropyrazolo[5,1-b][1,3]thiazol-6-ylmethyl)-N-hydroxyacetamide | —— | C8H11N3O2S |
|
—— | 2-((1-Methyl-1h-tetrazol-5-yl)thio)-1-(5-methylthiophen-2-yl)ethan-1-one | —— | C9H10N4OS2 |
|
—— | 1-{[4-ethyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}-3,3-dimethylbutan-2-one | —— | C14H19N3OS2 |
|
—— | 5-Thiophen-2-yl-3-[[1-(thiophen-2-ylmethyl)tetrazol-5-yl]sulfanylmethyl]-1,2-oxazole | —— | C14H11N5OS3 |
|
—— | 4,6-Diamino-2-[(3-chlorophenyl)methylsulfanyl]pyridine-3-carbonitrile | —— | C13H11ClN4S |
|
—— | (2R)-2-(4-methyl-1,3-thiazol-2-yl)-3-oxo-4-[1-(thiophen-2-ylmethyl)tetrazol-5-yl]sulfanylbutanenitrile | —— | C14H12N6OS3 |
|
—— | 4,6-Diamino-2-[(3-chlorophenyl)methylsulfanyl]pyridin-1-ium-3-carbonitrile | —— | C13H12ClN4S+ |
|
—— | 1-(3-Isocyanatopropyl)-4-propan-2-ylsulfanylbenzene | —— | C13H17NOS |
|
—— | (3R)-3-(4-cyclopentylsulfanylphenyl)-3-(methylamino)propan-1-ol | —— | C15H23NOS |
|
—— | (1R)-2-(propan-2-ylamino)-1-(4-propan-2-ylsulfanylphenyl)ethanol | —— | C14H23NOS |
|
—— | (3S)-3-(4-cyclopentylsulfanylphenyl)-3-(methylamino)propan-1-ol | —— | C15H23NOS |
|
—— | (3R)-3-cyclopropyl-3-(4-propan-2-ylsulfanylphenyl)propan-1-amine | —— | C15H23NS |
|
—— | (3S)-3-cyclopropyl-3-(4-propan-2-ylsulfanylphenyl)propan-1-amine | —— | C15H23NS |
|
—— | (1R)-1-(4-cyclopentylsulfanylphenyl)-2-(ethylamino)ethanol | —— | C15H23NOS |
|